Literature DB >> 90168

Phosphonoformate inhibition of visna virus replication.

B Sundquist, E Larner.   

Abstract

Phosphonoformate (PFA) inhibits multiplication of visna virus in sheep choroid plexus cells; a 50% reduction of virus yield was obtained by 20 to 80 microM PFA. Morphological changes, such as syncytial formation and cell degeneration, could be reversibly prevented by PFA. Cell growth was not significantly affected at 500 microM PFA, although prolonged treatment with 2 mM PFA did arrest cell growth. Cell-free reverse transcriptase activity primed with various synthetic template-primers was inhibited about 90% in the presence of 100 microM PFA. The results from kinetic experiments suggested that reverse transcriptase was utilized early but not late in the infection cycle. A structurally related substance, phosphonoacetate, did not inhibit visna virus multiplication and had no inhibitory effect on reverse transcriptase activity at a concentration of 500 microM.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90168      PMCID: PMC353395          DOI: 10.1128/JVI.30.3.847-851.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Visna, a demyelinating transmissible disease of sheep.

Authors:  B SIGURDSSON; P PALSSON; H GRIMSSON
Journal:  J Neuropathol Exp Neurol       Date:  1957-07       Impact factor: 3.685

2.  Trisodium phosphonoformate, a new antiviral compound.

Authors:  E Helgstrand; B Eriksson; N G Johansson; B Lannerö; A Larsson; A Misiorny; J O Norén; B Sjöberg; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

3.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

4.  Membrane changes associated with assembly of visna virus.

Authors:  M Dubois-Dalcq; T S Reese; O Narayan
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

5.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

Review 7.  The slow infection caused by visna virus.

Authors:  A T Haase
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

8.  Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.

Authors:  W M Shannon
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

9.  Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.

Authors:  K Stenberg; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

10.  Visna virus RNA synthesis.

Authors:  M Brahic; P Filippi; R Vigne; A T Haase
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

  10 in total
  11 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase.

Authors:  L Vrang; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.

Authors:  K B Frank; P A McKernan; R A Smith; D F Smee
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 4.  Antiviral drugs for AIDS. Current status and future prospects.

Authors:  E Sandström
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

5.  The significance of NT1, NT2, and NT3 antigens in epidemiological investigations of bovine group-B streptococcus infections.

Authors:  N E Jensen; B Berg
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

6.  Goat visna virus: isolation of a retrovirus related to visna virus of sheep.

Authors:  B Sundquist
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

7.  Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.

Authors:  H Thormar; J Balzarini; A Holy; J Jindrich; I Rosenberg; Z Debyser; J Desmyter; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.

Authors:  M Margalith; H Falk; A Panet
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

9.  Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity.

Authors:  D F Smee; P A McKernan; L D Nord; R C Willis; C R Petrie; T M Riley; G R Revankar; R K Robins; R A Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 10.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.